Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
K. Conlon, E. Lugli, H. Welles, S. Rosenberg +19 more

